The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
Status:
Completed
Trial end date:
2023-02-17
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety, and cost-effectiveness of DWP14012 40 mg compared to
esomeprazole magnesium enteric-coated tablets for the treatment of reflux esophagitis.